TW200631953A - Tetracyclic imidazo-benzodiazepines - Google Patents
Tetracyclic imidazo-benzodiazepinesInfo
- Publication number
- TW200631953A TW200631953A TW094143881A TW94143881A TW200631953A TW 200631953 A TW200631953 A TW 200631953A TW 094143881 A TW094143881 A TW 094143881A TW 94143881 A TW94143881 A TW 94143881A TW 200631953 A TW200631953 A TW 200631953A
- Authority
- TW
- Taiwan
- Prior art keywords
- substituted
- halogen
- lower alkyl
- cycloalkyl
- hydrogen
- Prior art date
Links
- KLNFAMGHSZQYHR-UHFFFAOYSA-N imidazo[4,5-i][1,2]benzodiazepine Chemical class C1=CC=NN=C2C3=NC=NC3=CC=C21 KLNFAMGHSZQYHR-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 229910052736 halogen Inorganic materials 0.000 abstract 7
- 150000002367 halogens Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 239000002475 cognitive enhancer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- MEYXEJCDZRDIFZ-UHFFFAOYSA-N imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine Chemical class C=1N2N=CN=C2C2=CC=CC=C2N2CN=CC2=1 MEYXEJCDZRDIFZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106556 | 2004-12-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200631953A true TW200631953A (en) | 2006-09-16 |
Family
ID=36129290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094143881A TW200631953A (en) | 2004-12-14 | 2005-12-12 | Tetracyclic imidazo-benzodiazepines |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7432256B2 (zh) |
| EP (1) | EP1828194B1 (zh) |
| JP (1) | JP4783380B2 (zh) |
| KR (1) | KR100923393B1 (zh) |
| CN (1) | CN101115756B (zh) |
| AR (1) | AR055005A1 (zh) |
| AT (1) | ATE396998T1 (zh) |
| AU (1) | AU2005315913B2 (zh) |
| BR (1) | BRPI0515800A (zh) |
| CA (1) | CA2590333C (zh) |
| DE (1) | DE602005007265D1 (zh) |
| ES (1) | ES2307230T3 (zh) |
| MX (1) | MX2007007115A (zh) |
| PL (1) | PL1828194T3 (zh) |
| RU (1) | RU2393161C2 (zh) |
| TW (1) | TW200631953A (zh) |
| WO (1) | WO2006063708A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008064318A2 (en) * | 2006-11-22 | 2008-05-29 | University Of Medicine And Dentistry Of New Jersey | Peripheral opioid receptor active compounds |
| US10206921B2 (en) | 2009-06-03 | 2019-02-19 | The Regents Of The University Of California | Methods and compositions for treating a subject for central nervous system (CNS) injury |
| CN101891706B (zh) * | 2010-04-09 | 2013-05-29 | 复旦大学 | 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途 |
| US20130150351A1 (en) * | 2010-06-03 | 2013-06-13 | Stanley T. Carmichael | Methods and compositions for treating a subject for central nervous system (cns) injury |
| US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| NZ722077A (en) * | 2013-12-20 | 2021-12-24 | Agenebio Inc | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| CN113264939A (zh) | 2015-06-19 | 2021-08-17 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法 |
| US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| US11505555B2 (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| US11414425B2 (en) | 2018-06-19 | 2022-08-16 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| US20250197390A1 (en) | 2022-03-16 | 2025-06-19 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Fused heterocyclic compound, and preparation method therefor and medical use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1143728A (en) | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
| DE3587913D1 (de) | 1984-01-19 | 1994-10-06 | Hoffmann La Roche | Imidazodiazepin-Derivate. |
| DK174086D0 (da) | 1986-04-16 | 1986-04-16 | Ferrosan As | Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme |
| US4897392A (en) | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
| TW201311B (zh) | 1991-06-17 | 1993-03-01 | Hoffmann La Roche | |
| TWI239333B (en) * | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
| MX2007004639A (es) * | 2004-10-20 | 2007-06-08 | Hoffmann La Roche | Derivados de imidazo-benzodiazepina. |
-
2005
- 2005-12-05 CA CA2590333A patent/CA2590333C/en not_active Expired - Fee Related
- 2005-12-05 ES ES05825935T patent/ES2307230T3/es not_active Expired - Lifetime
- 2005-12-05 CN CN2005800479250A patent/CN101115756B/zh not_active Expired - Fee Related
- 2005-12-05 BR BRPI0515800-1A patent/BRPI0515800A/pt not_active IP Right Cessation
- 2005-12-05 KR KR1020077015973A patent/KR100923393B1/ko not_active Expired - Fee Related
- 2005-12-05 AU AU2005315913A patent/AU2005315913B2/en not_active Ceased
- 2005-12-05 RU RU2007121767/04A patent/RU2393161C2/ru not_active IP Right Cessation
- 2005-12-05 PL PL05825935T patent/PL1828194T3/pl unknown
- 2005-12-05 DE DE602005007265T patent/DE602005007265D1/de not_active Expired - Lifetime
- 2005-12-05 EP EP05825935A patent/EP1828194B1/en not_active Expired - Lifetime
- 2005-12-05 AT AT05825935T patent/ATE396998T1/de active
- 2005-12-05 MX MX2007007115A patent/MX2007007115A/es active IP Right Grant
- 2005-12-05 JP JP2007545890A patent/JP4783380B2/ja not_active Expired - Fee Related
- 2005-12-05 WO PCT/EP2005/012993 patent/WO2006063708A1/en not_active Ceased
- 2005-12-08 US US11/297,691 patent/US7432256B2/en not_active Expired - Fee Related
- 2005-12-12 TW TW094143881A patent/TW200631953A/zh unknown
- 2005-12-12 AR ARP050105181A patent/AR055005A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008523125A (ja) | 2008-07-03 |
| CN101115756B (zh) | 2010-06-16 |
| KR20070089227A (ko) | 2007-08-30 |
| AR055005A1 (es) | 2007-08-01 |
| CN101115756A (zh) | 2008-01-30 |
| PL1828194T3 (pl) | 2008-11-28 |
| KR100923393B1 (ko) | 2009-10-23 |
| ATE396998T1 (de) | 2008-06-15 |
| MX2007007115A (es) | 2007-07-11 |
| DE602005007265D1 (de) | 2008-07-10 |
| RU2007121767A (ru) | 2009-01-27 |
| US7432256B2 (en) | 2008-10-07 |
| CA2590333C (en) | 2013-01-08 |
| EP1828194B1 (en) | 2008-05-28 |
| ES2307230T3 (es) | 2008-11-16 |
| EP1828194A1 (en) | 2007-09-05 |
| AU2005315913A1 (en) | 2006-06-22 |
| CA2590333A1 (en) | 2006-06-22 |
| RU2393161C2 (ru) | 2010-06-27 |
| AU2005315913B2 (en) | 2011-11-24 |
| BRPI0515800A (pt) | 2008-08-05 |
| US20060128691A1 (en) | 2006-06-15 |
| WO2006063708A1 (en) | 2006-06-22 |
| JP4783380B2 (ja) | 2011-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU90003A (sh) | Derivati imidazo/1,5-a/pirimido/5,4-d//1/benzazepina kao modulatori gaba a raceptora | |
| JP3828422B2 (ja) | 新規アザインドリル誘導体 | |
| IL189762A0 (en) | Isoxazolo derivatives as gaba a alpha5 inverse agonists | |
| MX2007006896A (es) | Fenil-metanonas bi- y triciclicas sustituidas como inhibidores del transportador 1 de glicina (glyt-1) para el tratamiento de la enfermedad de alzheimer. | |
| NO20071967L (no) | Imidazo-benzodiazepinderivater | |
| IL190398A0 (en) | Imidazo benzodiazepine derivatives | |
| CA2520898A1 (en) | Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof | |
| MX2010005753A (es) | Derivados de isoxazolo-pirazina. | |
| IL190867A0 (en) | 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives | |
| TW200736257A (en) | Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives | |
| TW200631953A (en) | Tetracyclic imidazo-benzodiazepines | |
| ATE438632T1 (de) | Aryl-4-ethinylisoxazolderivate | |
| TW200734328A (en) | Aryl-isoxazolo-4-yl-imidazo [1,5-a] pyridine derivatives | |
| JP2004532823A (ja) | ピペラジン誘導体 | |
| MX2007004250A (es) | Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos. | |
| TW200630371A (en) | Halogen substituted benzodiazepine derivatives | |
| TH80293A (th) | เตตระไซคลิก อิมมิดาโซ-เบนโซไดอะซีพิน | |
| MXPA04008880A (es) | Nuevos compuestos de benzoindolina, un proceso para su preparacion y las composiciones farmaceuticals que los contienen. | |
| TH79587A (th) | อนุพันธ์ของอิมิดาโซ-เบนโซไดอะซีพีน | |
| TW200635898A (en) | Benzoyl-tetrahydropyridine | |
| TH80294A (th) | ไบ-และไทรไซคลิค ซับสทิทิวเทด เฟนิล เมธาโนน | |
| TH85139A (th) | สารประกอบใหม่ |